Keystone Symposia offer Editors a unique window into yet unpublished research and field directions, as they peruse posters, short-talks, workshops, and plenary sessions. At the Hypoxia meeting next week, Science Editor for the Journal of Clinical Investigation (JCI) Elyse Dankoski, Ph.D. will be searching for stories for the upcoming Hypoxia Special Issue.
Here she shares some insights into what she is looking for, the publication process and curation of this special issue highlight– be sure to meet up with her at the meeting to share your work!
In addition, she will share her experiences and advice about publication, and her career path, with junior scientists in the Career Roundtable Workshop.
An Interview with the Journal of Clinical Investigation (JCI) Science Editor, Dr. Elyse Dankoski, Ph.D.
Why are you attending this conference? What do you hope to get out of it?
Dr. Dankoski: As an editor, I attend conferences with the goal of learning about areas outside of my expertise and appreciating the full landscape of work being done in a particular area. Keystone Symposia meetings provide a great opportunity for me to immerse myself in a topic such as Hypoxia. As reflected by this year’s Nobel Prize in Medicine award, this conference focuses on research that is well-recognized for its clinical relevance.
I also look forward to meeting members of this community to learn more about their individual work and long-term research interests.
How does this meeting fit into your publication’s recent coverage of this field?
Dr. Dankoski: This area of research is particularly relevant to my work at the JCI this year: I am currently organizing a review series focused on disease mechanisms and therapeutics related to hypoxia-inducible factors that will be published in the JCI in Fall 2020. The upcoming series on HIFs in disease mechanisms and therapeutics was developed by the JCI’s deputy editor, and Nobel Laureate, Gregg Semenza, who is speaking at this conference, and associate editor Akrit Sodhi.
Our upcoming review series focused on HIFs in disease mechanisms and therapeutics reflects the editorial board’s ongoing interest in oxygen-sensing mechanisms.
As the JCI’s reviews editor, my goal is to ensure each review covers relevant work and its implications clearly and with appropriate balance. By attending this conference, I hope to gain deeper insights that facilitate my work on the review series:
- What concepts are particularly engaging to the field right now?
- What remains controversial?
- What new basic research may translate well to the clinic, and what lies on the horizon?
Keep an eye on the JCI in Fall 2020 to read these HIF reviews!
What sessions, speakers and/or special workshops are you most looking forward to and why?
Dr. Dankoski: This conference is a great opportunity to better appreciate the breadth of research related to hypoxia and oxygen-sensing mechanisms. As an editor, I am always excited to learn about basic and translational research that will likely lead to transformative advances in medicine. It will be rewarding to hear about new and ongoing developments directly from the leaders and future leaders of the field.
In addition to attending research presentations, I will be participating in a Career Roundtable Workshop on Monday, January 20th from 2:30-4:30 PM (immediately prior to the evening’s plenary session) along with 5 other scientists.
I’m looking forward to discussing my career path and position as a journal editor with trainees who are exploring options for their next steps.
About the Author
Elyse Dankoski, Ph.D. is a Science Editor for the Journal of Clinical Investigation
She earned her PhD in Neurobiology from the University of North Carolina in 2014. In 2016, following a postdoc in the University of Washington’s Pharmacology department, she joined the Journal of Clinical Investigation’s editorial team. As the handling editor for JCI’s review articles, she enjoys learning about the latest advances across all disciplines of biomedical research.
Follow her coverage of the Hypoxia meeting on Twitter:
#KSHypoxia | @elysecdx, @jclinicalinvest